Prognia
Drug Database
🇺🇸US · FDA ApprovedNone (Tentative Approval)ANDA216223-001

ABACAVIR; DOLUTEGRAVIR; LAMIVUDINE(ABACAVIR)

Integrase inhibitors; Antivirals for treatment of HIV infections, combinations; Nucleoside and nucleotide reverse transcriptase inhibitors

Manufacturer: LAURUS LABS LTD

FDA Approval: 11/08/2022

Route: ORAL · TABLET

Active Ingredients

ABACAVIR 600MG; DOLUTEGRAVIR 50MG; LAMIVUDINE 300MG

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about ABACAVIR; DOLUTEGRAVIR; LAMIVUDINE — check interactions with your patient's full medication list, get dosing recommendations with renal/hepatic adjustments, and explore guideline-cited evidence.

Medical disclaimer: This drug information is intended for qualified healthcare professionals only. Always verify with the official FDA prescribing information before clinical use.